
India regulator examines Sun, Ranbaxy merger trading: source
MUMBAI (Reuters) - India's market regulator will ask Ranbaxy Laboratories and Sun Pharmaceutical Industries for more information about their planned $3.2 billion merger and seek trading data from stock exchanges...
